Figure 1From: Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and EthiopiaNumber of notified cases of confirmed malaria in KwaZulu-Natal by month [15]. A indicates reintroduction of dichlorodiphenyltrichloroethane (DDT) for indoor residual spraying of traditional structures in KwaZulu-Natal; B indicates introduction of community-based indoor residual spraying in neighbouring Southern Mozambique; C indicates the implementation of artemether/lumefantrine as first-line therapy in KwaZulu-Natal.Back to article page